“Living drug factories” may one day replace injections
Startup develops implantable, encased cells that live in the body and secrete insulin and other therapeutics.
Startup develops implantable, encased cells that live in the body and secrete insulin and other therapeutics.
Bringing drug trials to the virtual realm, Belinda Tan ’96 has found a way to cut entire process in half.
New fellowship program honoring trailblazing Nobel laureate awards four MIT postdocs focused on drug discovery and development.
MIT biological engineers discover why a promising drug failed in clinical trials.
Platform connects individual pieces of lab equipment, compiles data in the cloud for speedier, more accurate research.
Continuous-flow chemistry device used for drug production could find use in long-duration space missions.
NEWDIGS Initiative at MIT leads multi-stakeholder collaboration to design and pilot a sustainable, patient-centered innovation ecosystem for a target disease.
Collaboration with pharmaceutical giant will bring smart jet-injection device to market.
Industry leaders, patient advocates, and policymakers collaborate to make groundbreaking new therapies economically sustainable.
Red, green, and blue light can be used to control gene expression in engineered E. coli.
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Seed funding from the MIT Sandbox Innovation Fund helped Multiply Labs' founders launch their personalized dietary supplement startup.
Automated manufacturing could make it easier to develop and test new peptide drugs.
From EpiPen pricing to government oversight, the making of medicine impacts all aspects of modern health care.